Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
209 studies found for:    Open Studies | "Hyperlipidemias"
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
Conditions: Essential Hypertension;   Hyperlipidemia
Interventions: Drug: Atorvastatin;   Drug: Losartan;   Drug: Placebo;   Drug: HL-040XC
2 Not yet recruiting Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
Conditions: Chronic Smokers;   Hyperlipidemia
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: BioTurmin (Curcuma longa rhizomes extract);   Dietary Supplement: BioTurmin-WD (Water dispersible curcuminoids);   Dietary Supplement: MaQxan
3 Not yet recruiting Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
Conditions: Chronic Smokers;   Hyperlipidemia
Interventions: Other: Placebo;   Dietary Supplement: BioTurmin (Curcuma longa rhizomes extract);   Dietary Supplement: BioTurmin-WD (Water dispersible curcuminoids);   Dietary Supplement: MaQxan (Tagetes erecta flower extract)
4 Recruiting Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Condition: Hyperlipidemia
Interventions: Drug: Bococizumab (PF-04950615; RN316);   Other: Placebo
5 Not yet recruiting Acupuncture and Moxibustion for Hyperlipemia
Condition: Hyperlipidemias
Interventions: Other: acupuncture and moxibustion;   Drug: Simvastatin;   Other: Therapeutic Lifestyle Change
6 Recruiting Telemedicine Based Management of Hyperlipidemia
Condition: Hyperlipidemia
Intervention: Device: Self Monitoring Lipid Analyzer
7 Unknown  Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: rosuvastatin,fenofibrate;   Genetic: CYP2C9, UGT1A1, UGT1A3, OATP2, BCRP
8 Not yet recruiting The Effects of Rhus Coriaria L. (Sumac) on Serum Lipid Levels of Patients With Hyperlipidemia
Condition: Hyperlipidemias
Interventions: Drug: Rhus Coriaria L. (Sumac);   Drug: Placebo
9 Unknown  Jiangzhuo Prescription ,Fenofibrate and Placebo in the Treatment of Hyperlipidemia (Syndrome of Phlegm Obstruction)Clinical Study (JZF)
Conditions: Metabolic Syndromes;   Hyperlipidemia
Intervention:
10 Recruiting Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
Conditions: Hypertension;   Hyperlipidemia
Interventions: Drug: Telmisartan 80mg;   Drug: Rosuvastatin 20mg;   Drug: Rosuvastatin 10mg;   Drug: Placebo(for Telmisartan 80mg);   Drug: Placebo(for Rosuvastatin 20mg);   Drug: Placebo(for Rosuvastatin 10mg)
11 Unknown  Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients
Conditions: HIV;   Hyperlipidemia;   HIV Infections
Interventions: Drug: ezetimibe;   Drug: fenofibrate;   Drug: pravastatin
12 Recruiting Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Condition: Hyperlipidemia
Interventions: Drug: Bococizumab (PF-04950615;RN316);   Other: Placebo
13 Recruiting Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Condition: Hyperlipidemia
Interventions: Drug: Bococizumab (PF-04950615; RN316);   Other: Placebo
14 Recruiting Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
Condition: Hyperlipidemia, Familial Combined
Interventions: Drug: Atorvastatin 20mg;   Drug: Omega-3-acids ethylesters 90 4g;   Other: Placebo(Omega-3-acids ethylesters 90)
15 Recruiting Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
Condition: Mixed Hyperlipidemia
Interventions: Drug: Atorvastatin 10mg, fenofibric acid 135mg;   Drug: atorvastatin 20mg
16 Recruiting Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins
Condition: Hyperlipidemia
Interventions: Drug: Bococizumab (PF-04950615;RN316);   Drug: Atorvastatin;   Other: Placebo for Bococizumab (PF-04950615;RN316);   Other: Placebo for atorvastatin
17 Recruiting Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin(Cresnon®);   Drug: Rosuvastatin(Crestor®)
18 Unknown  The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients’ Lipid Profiles
Condition: Hyperlipidemia
Intervention: Drug: Lipid-lowing Tea
19 Unknown  Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
Conditions: Hyperlipidemia;   Coronary Artery Disease
Intervention: Drug: Rosuvastatin
20 Recruiting A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol
Condition: Hyperlipidemia
Interventions: Drug: Evacetrapib;   Drug: Atorvastatin;   Drug: Ezetimibe;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years